Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
This study has been withdrawn prior to enrollment.
(Due to slow accrual)
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Robert I. Haddad, MD, Dana-Farber Cancer Institute
First received: September 21, 2010
Last updated: March 8, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||September 2015|
|Primary Completion Date:||July 2012 (Final data collection date for primary outcome measure)|